IVF · INVO Fertility, Inc. · Insider Trading

The Reporting Person surrendered the shares of Common Stock to the Issuer without receiving any payment or other value in return.

The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

The option vests in four equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

The option vests in four equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

The option vests in twelve equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

The option vests in four equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

The option vests in four equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

The option vests in twelve equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

The option vests in twelve equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

The stock option vests in monthly increments over a period of twelve months from the date of grant.

The stock option vests in monthly increments over a period of twelve months from the date of grant.

The stock option vests in monthly increments over a period of three years from the date of grant.

The stock option vests in monthly increments over a period of twelve months from the date of grant.

The stock option vests in monthly increments over a period of three years from the date of grant.

The stock option vests in monthly increments over a period of twelve months from the date of grant.

The stock option vest in monthly increments over a period of twelve months from the date of grant.

The stock option vests in monthly increments over a period of three years from the date of grant.

The stock option vests in monthly increments over a period of twelve months from the date of grant.

The option vests in substantially equal monthly increments over a period of seven months from the grant date.

Represents an award of restricted stock units, which vest in substantially equal monthly increments over a period of seven months from the grant date.

AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Life Sciences Fund, L.P. (LS). (LS and together with QP and Cay, the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 400,559 shares of Common Stock of the Issuer (the Shares) held by QP, 133,516 Shares held by Cay and 625,000 Shares held by LS.

Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

This is a weighted average price

AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Life Sciences Fund, L.P. (LS). (LS and together with QP and Cay, the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 399,809 shares of Common Stock of the Issuer (the Shares) held by QP, 133,266 Shares held by Cay and 625,000 Shares held by LS.

Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

This is a weighted average price.

This is a weighted average price.

This is a weighted average price.